IONS in “The Patent Cliff Sparks a Biotech Land Grab”
Ionis Pharmaceuticals, Inc.
Ionis offers a clinically validated RNA-targeting platform and a growing roster of wholly owned and partnered medicines that can attract licensing capital.
IONS impact map — “The Patent Cliff Sparks a Biotech Land Grab”
How this story travels from the headline to IONS’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading IONS impact map…
Price history, marked with story events
Oct 5, 2026 – Oct 16, 2026 · 10 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
The Patent Cliff Sparks a Biotech Land Grab
Large drugmakers facing revenue holes must buy scarce pipelines, turning clinical validation into strategic currency.
BULL side — Ionis offers a clinically validated RNA-targeting platform and a growing roster of wholly owned and partnered medicines that can attract licensing capital.
Read the full The Patent Cliff Sparks a Biotech Land Grab story